Indonesia — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans

← back to leaderboard

Indonesia received 19 FDA import refusals in Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q4 and 2026-Q3. Volume peaked at 6 in 2023-Q4, with the trend roughly flat year-on-year. The most-cited issues are unsfdietsp, ndidietsp, and unapproved. No trade baseline is published for this commodity from Indonesia, so no per-$1B rate is shown here.

Of these, 2 were hazard refusals and 17 were paperwork refusals.

Exporting from Indonesia? Get an email when shipments from Indonesia are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

6 2023-Q4 2023-Q4: 6 5 2024-Q1 2024-Q1: 5 4 2024-Q2 2024-Q2: 4 0 2024-Q3 2024-Q3: 0 1 2024-Q4 2024-Q4: 1 1 2025-Q1 2025-Q1: 1 0 2025-Q2 2025-Q2: 0 0 2025-Q3 2025-Q3: 0 0 2025-Q4 2025-Q4: 0 1 2026-Q1 2026-Q1: 1 0 2026-Q2 2026-Q2: 0 1 2026-Q3 2026-Q3: 1

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Herbals-Botanicals 18 unsfdietsp
Supplements 1 unapproved

Recent rejections